We could not find any results for:
Make sure your spelling is correct or try broadening your search.
MALVERN, Pa., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company historically focused on developing a pipeline of novel...
MALVERN, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel, proprietary...
MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics that have...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | -0.0393 | -21.3239283776 | 0.1843 | 0.2345 | 0.1354 | 2097023 | 0.16916855 | CS |
26 | -0.024 | -14.201183432 | 0.169 | 0.29 | 0.1314 | 1944991 | 0.19694046 | CS |
52 | -0.1777 | -55.0666253486 | 0.3227 | 0.3227 | 0.0853 | 2798732 | 0.19091447 | CS |
156 | -8.025 | -98.2252141983 | 8.17 | 9.32 | 0.0853 | 2249275 | 1.83183443 | CS |
260 | -12.355 | -98.84 | 12.5 | 19.5 | 0.0853 | 1427587 | 2.12123817 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions